Skip to content

Prognosis of metastatic lung cancer in the real-world setting.: A multi-center retrospective cohort study (REAL-WIND study)(WJOG15121L)

Prognosis of metastatic lung cancer in the real-world setting.: A multi-center retrospective cohort study - REAL-WIND

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000044957
Enrollment
6000
Registered
2021-10-01
Start date
2021-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

None listed

Sponsors

West Japan Oncology Group
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Stage IV lung cancer according to TNM classification 8th edition 2) Patients who were first diagnosed with the above at a participating institution between January 1, 2016 and December 31, 2020.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Overall survival, and accuracy of overall survival prediction model created by machine learning

Secondary

MeasureTime frame
Percentage of patients treated with anti-cancer therapy Time to treatment failure Progression-free survival Severe adverse events Factors related to prognosis Percentage of missing values

Countries

Japan

Contacts

Public ContactShinichiro Nakamura

West Japan Oncology Group WJOG datacenter

datacenter@wjog.jp06-6633-7400

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026